Stryker PE Ratio 2010-2025 | SYK
Current and historical p/e ratio for Stryker (SYK) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Stryker PE ratio as of July 25, 2025 is 32.21.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Stryker PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-25 | 403.53 | 54.53 | |
| 2025-03-31 | 371.46 | $7.40 | 50.20 |
| 2024-12-31 | 358.45 | $7.76 | 46.19 |
| 2024-09-30 | 358.82 | $9.33 | 38.46 |
| 2024-06-30 | 337.21 | $8.97 | 37.59 |
| 2024-03-31 | 353.84 | $8.76 | 40.39 |
| 2023-12-31 | 295.41 | $8.25 | 35.81 |
| 2023-09-30 | 268.85 | $6.74 | 39.89 |
| 2023-06-30 | 299.31 | $7.08 | 42.28 |
| 2023-03-31 | 279.36 | $6.87 | 40.66 |
| 2022-12-31 | 238.62 | $6.17 | 38.67 |
| 2022-09-30 | 197.06 | $6.43 | 30.65 |
| 2022-06-30 | 192.90 | $5.43 | 35.52 |
| 2022-03-31 | 258.33 | $5.26 | 49.11 |
| 2021-12-31 | 257.74 | $5.21 | 49.47 |
| 2021-09-30 | 253.52 | $4.97 | 51.01 |
| 2021-06-30 | 249.10 | $5.46 | 45.62 |
| 2021-03-31 | 233.04 | $3.69 | 63.16 |
| 2020-12-31 | 233.83 | $4.20 | 55.67 |
| 2020-09-30 | 198.32 | $4.61 | 43.02 |
| 2020-06-30 | 171.02 | $4.21 | 40.62 |
| 2020-03-31 | 157.50 | $5.69 | 27.68 |
| 2019-12-31 | 197.88 | $5.48 | 36.11 |
| 2019-09-30 | 203.32 | $9.02 | 22.54 |
| 2019-06-30 | 192.78 | $9.34 | 20.64 |
| 2019-03-31 | 184.74 | $9.27 | 19.93 |
| 2018-12-31 | 146.22 | $9.34 | 15.66 |
| 2018-09-30 | 165.19 | $3.24 | 50.98 |
| 2018-06-30 | 156.57 | $2.83 | 55.33 |
| 2018-03-31 | 148.79 | $2.67 | 55.73 |
| 2017-12-31 | 142.75 | $2.68 | 53.26 |
| 2017-09-30 | 130.53 | $4.68 | 27.89 |
| 2017-06-30 | 127.17 | $4.48 | 28.39 |
| 2017-03-31 | 120.27 | $4.45 | 27.03 |
| 2016-12-31 | 109.10 | $4.35 | 25.08 |
| 2016-09-30 | 105.63 | $4.39 | 24.06 |
| 2016-06-30 | 108.39 | $4.24 | 25.56 |
| 2016-03-31 | 96.72 | $4.27 | 22.65 |
| 2015-12-31 | 83.48 | $3.78 | 22.09 |
| 2015-09-30 | 84.18 | $3.07 | 27.42 |
| 2015-06-30 | 85.19 | $2.44 | 34.92 |
| 2015-03-31 | 81.94 | $1.97 | 41.59 |
| 2014-12-31 | 83.47 | $1.57 | 53.17 |
| 2014-09-30 | 71.20 | $1.91 | 37.28 |
| 2014-06-30 | 74.07 | $2.02 | 36.67 |
| 2014-03-31 | 71.31 | $2.02 | 35.30 |
| 2013-12-31 | 65.51 | $2.63 | 24.91 |
| 2013-09-30 | 58.69 | $2.33 | 25.19 |
| 2013-06-30 | 55.95 | $2.98 | 18.78 |
| 2013-03-31 | 56.20 | $3.27 | 17.19 |
| 2012-12-31 | 47.03 | $3.39 | 13.87 |
| 2012-09-30 | 47.53 | $3.73 | 12.74 |
| 2012-06-30 | 46.87 | $3.65 | 12.84 |
| 2012-03-31 | 47.00 | $3.59 | 13.09 |
| 2011-12-31 | 41.95 | $3.46 | 12.13 |
| 2011-09-30 | 39.61 | $3.15 | 12.57 |
| 2011-06-30 | 49.14 | $3.16 | 15.55 |
| 2011-03-31 | 50.75 | $3.17 | 16.01 |
| 2010-12-31 | 44.69 | $3.19 | 14.01 |
| 2010-09-30 | 41.51 | $3.21 | 12.93 |
| 2010-06-30 | 41.40 | $2.93 | 14.13 |
| 2010-03-31 | 47.18 | $2.86 | 16.49 |
| 2009-12-31 | 41.42 | $2.77 | 14.95 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $154.023B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $220.159B | 25.82 |
| Boston Scientific (BSX) | United States | $157.028B | 37.51 |
| EssilorLuxottica (ESLOY) | France | $136.572B | 0.00 |
| Medtronic (MDT) | Ireland | $119.200B | 16.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.282B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.384B | 25.33 |
| ResMed (RMD) | United States | $40.346B | 30.30 |
| GE HealthCare Technologies (GEHC) | United States | $35.536B | 16.87 |
| Agilent Technologies (A) | United States | $34.139B | 22.26 |
| Terumo (TRUMY) | Japan | $25.843B | 33.57 |
| Koninklijke Philips (PHG) | Netherlands | $25.190B | 17.68 |
| Insulet (PODD) | United States | $20.424B | 80.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.300B | 12.40 |
| Baxter (BAX) | United States | $14.995B | 11.20 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.871B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.189B | 25.02 |
| Lantheus Holdings (LNTH) | United States | $5.046B | 12.73 |
| Perrigo (PRGO) | Ireland | $3.908B | 9.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.799B | 16.97 |
| Haemonetics (HAE) | United States | $3.613B | 16.46 |
| Envista Holdings (NVST) | United States | $3.525B | 29.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.197B | 23.58 |
| LeMaitre Vascular (LMAT) | United States | $1.862B | 41.63 |
| QuidelOrtho (QDEL) | United States | $1.852B | 12.74 |
| AtriCure (ATRC) | United States | $1.559B | 0.00 |
| Acuren (TIC) | United States | $1.441B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.332B | 29.95 |
| AdaptHealth (AHCO) | United States | $1.274B | 12.93 |
| Phibro Animal Health (PAHC) | United States | $1.183B | 15.12 |
| Neogen (NEOG) | United States | $1.133B | 14.50 |
| BioLife Solutions (BLFS) | United States | $1.080B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.964B | 0.00 |
| InMode (INMD) | Israel | $0.930B | 9.38 |
| Kestra Medical Technologies (KMTS) | United States | $0.850B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.693B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.685B | 0.00 |
| Valneva SE (VALN) | France | $0.654B | 0.00 |
| Evolus (EOLS) | United States | $0.614B | 0.00 |
| Owens & Minor (OMI) | United States | $0.609B | 5.05 |
| CeriBell (CBLL) | United States | $0.547B | 0.00 |
| ZimVie (ZIMV) | United States | $0.521B | 23.70 |
| Surmodics (SRDX) | United States | $0.515B | 0.00 |
| SNDL (SNDL) | Canada | $0.398B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.359B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.336B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.324B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Capricor Therapeutics (CAPR) | United States | $0.322B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.272B | 80.67 |
| Cerus (CERS) | United States | $0.266B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.251B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.242B | 20.40 |
| Biote (BTMD) | United States | $0.236B | 6.65 |
| Canopy Growth (CGC) | Canada | $0.234B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.230B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.227B | 0.00 |
| Omeros (OMER) | United States | $0.224B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.65 |
| Organigram Global (OGI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.65 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Exagen (XGN) | United States | $0.155B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.121B | 14.91 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.86 |
| Quipt Home Medical (QIPT) | United States | $0.097B | 0.00 |
| Apyx Medical (APYX) | United States | $0.096B | 0.00 |
| Safety Shot (SHOT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.082B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.29 |
| Nephros (NEPH) | United States | $0.038B | 51.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |